Usefulness of a large automated health records database in pharmacoepidemiology

Environmental Health and Preventive Medicine

Volumn 16, Issue 5, 2011, Pages 313-319

  Hashikata, Hirokuni ^a   Harada, Kouji H ^a   Kagimura, Tatsuo ^b   Nakamura, Masaki ^c   Koizumi, Akio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NIPPON BOEHRINGER INGELHEIM CO LTD   (Japan)

^c Business Development Department   (Japan)

Author keywords

Automated health records database; Cardio cerebrovascular events; Diabetes mellitus; Hypertension; Pharmacoepidemiology

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C;

AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH CARE FACILITY; HEALTH INSURANCE; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PHARMACOEPIDEMIOLOGY; SUBARACHNOID HEMORRHAGE;

AGED; ANTIHYPERTENSIVE AGENTS; CEREBROVASCULAR DISORDERS; COHORT STUDIES; DATABASES, FACTUAL; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHARMACOEPIDEMIOLOGY; RENAL DIALYSIS;

EID: 80052486816     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1007/s12199-010-0201-y     Document Type: Article

References (5)

1. S Johansson MA Wallander FJ de Abajo LA Garcia Rodriguez 2010 Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenarios Drug Saf 33 223 232 20158286 10.2165/11319010-000000000-00000
2. S Kimura T Sato S Ikeda M Noda T Nakayama 2010 Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage J Epidemiol 20 413 419 20699602 10.2188/jea.JE20090066
3. Arima H, Tanizaki Y, Yonemoto K, Doi Y, Ninomiya T, Hata J, Fukuhara M, Matsumura K, Iida M, Kiyohara Y. Impact of blood pressure levels on different types of stroke: the Hisayama study. J Hypertens. 2009;27:2437-43.
4. S Mochizuki B Dahlof M Shimizu K Ikewaki M Yoshikawa I Taniguchi M Ohta T Yamada K Ogawa K Kanae M Kawai S Seki F Okazaki M Taniguchi S Yoshida N Tajima 2007 Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study Lancet 369 1431 1439 17467513 10.1016/S0140-6736(07)60669-2 1:CAS:528:DC%2BD2sXkslWlsrc%3D (Pubitemid 46635780)
5. T Sawada H Yamada B Dahlof H Matsubara 2009 Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study Eur Heart J 30 2461 2469 19723695 10.1093/eurheartj/ehp363 1:CAS:528:DC%2BD1MXht12ht7vL